Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT

OBJECTIVE: Cross-sectional studies found less microalbuminuria in type 2 diabetic patients with the Ala12 allele of the peroxisome proliferator–activated receptor-γ2 (PPAR-γ2) Pro12Ala polymorphism. We prospectively evaluated the association between Pro12Ala polymorphism (rs1801282) and new-onset mi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Cosmo, Salvatore, Motterlini, Nicola, Prudente, Sabrina, Pellegrini, Fabio, Trevisan, Roberto, Bossi, Antonio, Remuzzi, Giuseppe, Trischitta, Vincenzo, Ruggenenti, Piero
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780880/
https://www.ncbi.nlm.nih.gov/pubmed/19720797
http://dx.doi.org/10.2337/db09-0407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780880/
https://www.ncbi.nlm.nih.gov/pubmed/19720797
http://dx.doi.org/10.2337/db09-0407

Ejemplares similares